FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37026711000001108: Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
45061000001115 Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
45071000001113 Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) Is a Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Abacavir true Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Lamivudine true Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Abacavir false Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) Is a Abacavir 600mg / Lamivudine 300mg tablets false Inferred relationship Existential restriction modifier
Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) Is a Abacavir 600mg / Lamivudine 300mg tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has AMP True Abacavir 600mg / Lamivudine 300mg tablets (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start